Yahoo
NasdaqGS - Delayed Quote USD

Merit Medical Systems, Inc. (MMSI)

89.60 +1.03 (+1.16%)
At close: September 4 at 4:00:01 PM EDT
89.60 0.00 (0.00%)
After hours: September 4 at 7:30:04 PM EDT
Trade MMSI on Coinbase
Chart Range Bar
Loading chart for MMSI
  • Previous Close 88.57
  • Open 87.69
  • Bid 63.63 x 200
  • Ask 113.01 x 200
  • Day's Range 87.04 - 89.69
  • 52 Week Range 59.74 - 94.75
  • Volume 599,642
  • Avg. Volume 887,587
  • Market Cap (intraday) 5.35B
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) 36.87
  • EPS (TTM) 2.43
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 101.45

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

www.merit.com

7,500

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MMSI
1.66%
S&P 500 (^GSPC)
12.75%

1-Year Return

MMSI
2.77%
S&P 500 (^GSPC)
18.71%

3-Year Return

MMSI
37.21%
S&P 500 (^GSPC)
70.93%

5-Year Return

MMSI
22.76%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 418.84M
Earnings 38.8M
Profit Margin 9.26%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
400M
8.0%
9.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

83.00 Low
101.45 Average
89.60 Current
123.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/13/2026
Analyst B of A Securities
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 92 -> 97

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.22%

  • Return on Assets (ttm)

    4.92%

  • Return on Equity (ttm)

    9.19%

  • Revenue (ttm)

    1.58B

  • Net Income Avi to Common (ttm)

    145.56M

  • Diluted EPS (ttm)

    2.43

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    448.7M

  • Total Debt/Equity (mrq)

    48.82%

  • Levered Free Cash Flow (ttm)

    173.9M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: